CBP501/Cisplatin/Nivolumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CBP501/Cisplatin/Nivolumab, covering 2023-08-15 to 2023-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer [Phase 2]